scholarly article | Q13442814 |
P50 | author | Aristi P. Fernandes | Q37610348 |
Maria Pia Rigobello | Q47136370 | ||
Valentina Gandin | Q57033119 | ||
Cristina Marzano | Q60971087 | ||
Francesco Tisato | Q88611404 | ||
Alberto Bindoli | Q115160275 | ||
Francesca Sorrentino | Q115160324 | ||
Mikael Björnstedt | Q115160326 | ||
P2093 | author name string | Alberto Sturaro | |
Rocco Rella | |||
Barbara Dani | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell death | Q2383867 |
P304 | page(s) | 90-101 | |
P577 | publication date | 2009-08-07 | |
P1433 | published in | Biochemical Pharmacology | Q864229 |
P1476 | title | Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase | |
P478 | volume | 79 |
Q89598952 | A Novel Assay Method to Determine the β-Elimination of Se-Methylselenocysteine to Monomethylselenol by Kynurenine Aminotransferase 1 |
Q42239873 | A triclinic polymorph of tri-cyclo-hexyl-phosphane sulfide: crystal structure and Hirshfeld surface analysis |
Q40651065 | Activity of phosphino palladium(II) and platinum(II) complexes against HIV-1 and Mycobacterium tuberculosis |
Q34931100 | Alteration of thioredoxin reductase 1 levels in elucidating cancer etiology |
Q37833099 | Anticancer Activity of Metal Complexes: Involvement of Redox Processes |
Q38917659 | Antioxidant enzyme inhibitor role of phosphine metal complexes in lung and leukemia cell lines. |
Q34049230 | Antiproliferative effect of gold(I) compound auranofin through inhibition of STAT3 and telomerase activity in MDA-MB 231 human breast cancer cells |
Q36546701 | Auranofin induces apoptosis by ROS-mediated ER stress and mitochondrial dysfunction and displayed synergistic lethality with piperlongumine in gastric cancer |
Q34231446 | Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia |
Q33829292 | Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species. |
Q34774888 | Auranofin, an anti-rheumatic gold compound, modulates apoptosis by elevating the intracellular calcium concentration ([ca2+]I) in mcf-7 breast cancer cells. |
Q36772192 | Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells |
Q37745339 | Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer |
Q50479237 | Developmental toxicity of auranofin in zebrafish embryos |
Q41281464 | Differential expression of disulfide reductase enzymes in a free-living platyhelminth (Dugesia dorotocephala). |
Q37001194 | Drug Repurposing for Gastrointestinal Stromal Tumor |
Q35060920 | Effect of 2-chloro-substitution of adenine moiety in mixed-ligand gold(I) triphenylphosphine complexes on anti-inflammatory activity: the discrepancy between the in vivo and in vitro models |
Q28579069 | Effects of hyperoxia on cytoplasmic thioredoxin system in alveolar type epithelial cells of premature rats |
Q39457061 | Effects of redox modulation by inhibition of thioredoxin reductase on radiosensitivity and gene expression. |
Q47712025 | Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes. |
Q39746460 | Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study |
Q35682793 | Exposure to silver nanoparticles inhibits selenoprotein synthesis and the activity of thioredoxin reductase |
Q49789150 | Glutathione peroxidase 4 overexpression inhibits ROS-induced cell death in diffuse large B-cell lymphoma |
Q92724049 | Gold as a Possible Alternative to Platinum-Based Chemotherapy for Colon Cancer Treatment |
Q28243207 | Gold compounds as therapeutic agents for human diseases |
Q28543014 | Gold(I)-triphenylphosphine complexes with hypoxanthine-derived ligands: in vitro evaluations of anticancer and anti-inflammatory activities |
Q39493102 | Gold(i) complexes of water-soluble diphos-type ligands: Synthesis, anticancer activity, apoptosis and thioredoxin reductase inhibition |
Q89069255 | Gold-Based Medicine: A Paradigm Shift in Anti-Cancer Therapy? |
Q33951227 | Hepatocytes lacking thioredoxin reductase 1 have normal replicative potential during development and regeneration |
Q47652117 | Historical and biochemical aspects of a seventeenth century gold-based aurum vitae recipe |
Q36376153 | Human Serum Albumin-Delivered [Au(PEt3)]+ Is a Potent Inhibitor of T Cell Proliferation |
Q39185517 | Human cancerous and healthy cell cytotoxicity studies of a chiral μ-dicarbene-digold(I) metallamacrocycle |
Q28533669 | Identification of therapeutic candidates for chronic lymphocytic leukemia from a library of approved drugs |
Q35446994 | Iminophosphorane-organogold(III) complexes induce cell death through mitochondrial ROS production |
Q30920586 | Impedance technology reveals correlations between cytotoxicity and lipophilicity of mono and bimetallic phosphine complexes |
Q31148784 | In Vitro Antitumor Active Gold(I) Triphenylphosphane Complexes Containing 7-Azaindoles. |
Q55429885 | In vitro antineoplastic effects of auranofin in canine lymphoma cells. |
Q90264057 | Iron (II) Polypyridyl Complexes as Antiglioblastoma Agents to Overcome the Blood-Brain Barrier and Inhibit Cell Proliferation by Regulating p53 and 4E-BP1 Pathways |
Q37709144 | Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer. |
Q35448162 | Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson's disease |
Q36021556 | Luminescent Di‐ and Polynuclear Organometallic Gold(I)–Metal (Au2, {Au2Ag}n and {Au2Cu}n) Compounds Containing Bidentate Phosphanes as Active Antimicrobial Agents |
Q39049711 | Luminescent alkynyl-gold(I) coumarin derivatives and their biological activity |
Q90678045 | Manipulation of Glucose and Hydroperoxide Metabolism to Improve Radiation Response |
Q33805225 | Metal complexes as potential modulators of inflammatory and autoimmune responses |
Q26800031 | Metal- and Semimetal-Containing Inhibitors of Thioredoxin Reductase as Anticancer Agents |
Q98200506 | Mitochondrial TXNRD3 confers drug resistance via redox-mediated mechanism and is a potential therapeutic target in vivo |
Q43153890 | Mitochondrial respiratory chain involvement in peroxiredoxin 3 oxidation by phenethyl isothiocyanate and auranofin. |
Q38718171 | Mononuclear gold(iii) complexes with l-histidine-containing dipeptides: tuning the structural and biological properties by variation of the N-terminal amino acid and counter anion. |
Q39113331 | Ni(II) and Cu(II) N(4)-ethylmorpholine citronellalthiosemicarbazonate: a comparative analysis of cytotoxic effects in malignant human cancer cell lines |
Q61958115 | Nicotinamide Nucleotide Transhydrogenase as a Novel Treatment Target in Adrenocortical Carcinoma |
Q38796911 | Novel antitumor adamantane-azole gold(I) complexes as potential inhibitors of thioredoxin reductase. |
Q91690519 | Oxidative Stress Induced by the Deubiquitinase Inhibitor b-AP15 Is Associated with Mitochondrial Impairment |
Q92080320 | Pentathiepins: a novel class of glutathione peroxidase 1 inhibitors that induce oxidative stress, loss of mitochondrial membrane potential and apoptosis in human cancer cells |
Q92493928 | Pharmacokinetics and Tissue Distribution of a Novel Bis-Chelated Gold(I) Diphosphine Compound, Bis(2,3-bis(tert-butylmethylphosphino)Quinoxaline)Aurate(I), in Rats |
Q37714208 | Phosphinogold(I) dithiocarbamate complexes: effect of the nature of phosphine ligand on anticancer properties |
Q90929522 | ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin |
Q36140846 | Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells. |
Q46894751 | Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase |
Q42116442 | Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration-Approved Drugs |
Q64055412 | Studies on the Interaction between Poly-Phosphane Gold(I) Complexes and Dihydrofolate Reductase: An Interplay with Nicotinamide Adenine Dinucleotide Cofactor |
Q39495236 | Studies on the cytotoxic, apoptotic and antitumoral effects of Au(III) and Pt(II) complexes of 1, 10-phenanthroline on V79 379A and A549 cell lines |
Q38755076 | Synergistic induction of apoptosis by combination treatment with mesupron and auranofin in human breast cancer cells |
Q39385088 | Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents |
Q52893904 | Synthesis, cytotoxicity and anti-cancer activity of new alkynyl-gold(I) complexes. |
Q38897130 | Synthesis, reactivity, and biological activity of gold(I) complexes modified with thiourea-functionalized tyrosine kinase inhibitors |
Q37808628 | Targeting selenium metabolism and selenoproteins: novel avenues for drug discovery |
Q40229976 | The Enzymatic and Structural Basis for Inhibition of Echinococcus granulosus Thioredoxin Glutathione Reductase by Gold(I). |
Q39126478 | The influence of R substituents in triphenylphosphinegold(I) carbonimidothioates, Ph3PAu[SC(OR)=NPh] (R=Me, Et and iPr), upon in vitro cytotoxicity against the HT-29 colon cancer cell line and upon apoptotic pathways |
Q39111089 | The relationship between electrospray ionization behavior and cytotoxic activity of [M(I)(P)4](+)-type complexes (M = Cu, Ag and Au; P = tertiary phosphine). |
Q36430099 | Thioredoxin reductase 1 deficiency enhances selenite toxicity in cancer cells via a thioredoxin-independent mechanism |
Q50686302 | Toxicity assessment of 7 anticancer compounds in zebrafish |
Q89870257 | Triethylphosphinegold(I) Complexes with Secnidazole-Derived Thiosemicarbazones: Cytotoxic Activity against HCT-116 Colorectal Cancer Cells under Hypoxia Conditions |
Search more.